Non-residential construction volumes and pricing continued their upward trend in the second quarter, with prices increasing an average of 2 to 4 percent in the first half of 2013. These factors, along with growing market confidence and a narrowing labor supply, will continue to push new construction costs closer to the trend line for the near to medium term.
Translational Research Institute (TRI) is a joint venture between The University of Queensland Diamantina Institute, Queensland University of Technology’s Institute of Health and Biomedical Innovation, Mater Research, and the Princess Alexandra Hospital Centres for Health Research.
Institutions that allow research strategy to drive their infrastructure will forge productive relationships with their primary investigators (PIs) from the start and yield better research results. The University Health Network (UHN) in Toronto, Canada, has successfully instituted procedures to take into account the financial and facility impact of potential research hires, which has positively impacted recruitment efforts and strengthened its research program.
The University of Florida celebrated the opening of the $45 million Clinical and Translational Science Building in Gainesville in August of 2013. The collaborative 120,000-sf project houses the 40,000-sf UF Institute on Aging, the Clinical and Translational Research Institute, conference rooms, training facilities, research laboratories, and clinical space. LEED Platinum sustainable design certification will be sought for the facility.
Queensland Children's Hospital is building the $125 million Academic and Research Facility (A&RF) in Brisbane. Created in partnership with the University of Queensland, Queensland University of Technology, and the Translational Research Institute, the ten-story project will provide five floors of wet and dry labs for advanced biomedical research. The remaining levels will house pathology services, retail, and parking. While the facility will house more than 450 researchers, the design allows for expansion.
Loyola University Chicago will break ground in August of 2013 on the $137 million Center for Translational Research and Education. Created in partnership with CHE-Trinity, the five-story, 227,000-sf facility will provide open labs and support space for research in epidemiology, public health, bioinformatics, nursing, and health sciences. The center will accommodate 72 principal investigators and will include a 250-seat auditorium. Occupancy is expected in August of 2016.
The University of Minnesota will break ground in fall of 2013 on a $63 million microbiology research facility in Minneapolis. The 80,000-sf project will be the final building to be constructed in UM's $292 million Biomedical Discovery District and will house the Department of Microbiology and other departments and schools within the Academic Health Center. Designed by BWBR Architects, the facility will provide labs, offices, collaboration areas, pharmaceutical R&D suites, and biocontainment space for the study of infectious diseases.
The Vaccine and Gene Therapy Institute of Florida (VGTI), an offshoot of the VGTI at Oregon Health and Science University, is dedicated to developing vaccines and immunotherapies to combat diseases such as AIDS, cancer, tuberculosis, and diseases associated with emerging viral infections such as Dengue fever and pandemic influenza. The three-story, 101,000-sf facility contains 11,000 nsf of vivarium/containment space with integrated procedure and in-vivo imaging spaces, nine bioscience research lab groups, specialty support labs, offices, and conference space.
The University of Bristol is building the $82 million Life Sciences building in the United Kingdom. The 145,313-sf facility will provide teaching and research labs, seminar rooms, and offices arranged around a central atrium. Supporting advanced biological sciences research, the building will include a five-story laboratory wing with microscopy and spectroscopy rooms, acoustic chambers, cleanrooms, and greenhouses. The project was designed by Sheppard Robson and is being built by VINCI Construction.
Pfizer is investing $130 million to expand its pharmaceutical manufacturing operations in Ireland. Pfizer's Grange Castle campus in Clondalkin will undergo a $100 million renovation and expansion to double current production of therapies for rheumatoid arthritis. Completion is expected in 2015. A $23 million upgrade of the Ringaskiddy campus will support the manufacture of new cancer treatments and other medicines.
The Mayo Clinic is expanding in Phoenix with the construction of a 380,000-sf, six-story cancer treatment center. The project includes a $181.5 million proton therapy facility located on the 100,000-sf concourse level of the building with two stories underground. Walls of high density concrete will provide radiation containment for the center, which will include four treatment rooms and its own central plant. Ground was broken on the facility in late 2011 and occupancy is expected in 2016.
The University of Miami is building the 37,000-sf Neuroscience and Health Annex in Coral Gables, Fla. The interdisciplinary facility will enable scientists from the departments of biology and psychology to collaborate with researchers from the Miller School of Medicine. The three-story project is partially funded by $14.8 million in federal stimulus funding and will provide research labs, offices, a vivarium, and a human functional magnetic resonance imaging lab (HFMRI). LEED Silver sustainable design certification will be sought for the facility.
The recently opened Translational Research Institute (TRI) in Brisbane, Australia, combines four major research institutes into a single medical and biopharmaceutical research facility where new treatments can be developed, manufactured, and clinically tested in one location, greatly shortening the time between discovery and application.
Brigham and Women's Hospital broke ground in June of 2013 on the $450 million Brigham Building for the Future in Boston. The 620,000-sf, 11-story translational facility will provide advanced laboratories, clinical space, and a subterranean imaging center to support the integration of research with patient care. LEED Gold sustainable design certification will be sought for the project, which will feature a cogeneration plant and a storm water recycling system. Completion is expected in fall of 2016.
Michigan State University broke ground in June of 2013 on the $60.8 million Bio Engineering Facility in East Lansing. The 130,000-sf interdisciplinary building will provide modular open-plan laboratories and offices for faculty from the colleges of Engineering, Human Medicine, and Natural Science.
